22nd Century Group Inc (NASDAQ:XXII)

0.6236
Delayed Data
As of 4:00pm ET
 -0.0181 / -2.82%
Today’s Change
0.58
Today|||52-Week Range
2.70
-32.25%
Year-to-Date
No recent news for 22nd Century Group Inc.

Today’s Trading

Previous close0.64
Today’s open0.65
Day’s range0.61 - 0.67
Volume16,281
Average volume (3 months)1,075,178
Market cap$138.5M
Data as of 4:00pm ET, 05/31/2023

Growth & Valuation

Earnings growth (last year)-47.46%
Earnings growth (this year)+10.32%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+100.69%
P/E ratioNM
Price/Sales2.86
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...-0.03-2.94%
INMBINmune Bio Inc-0.19-2.41%
PLXProtalix Biotherapeu...+0.08+3.98%
LRMRLarimar Therapeutics...+0.12+3.33%
Data as of 4:00pm ET, 05/31/2023

Financials

Next reporting dateAugust 8, 2023
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$62.1M
Annual profit (last year)-$59.8M
Net profit margin-96.28%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Buffalo, New York

Forecasts